ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Novitzky, D.
Right arrow Articles by Barnard, C. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Novitzky, D.
Right arrow Articles by Barnard, C. N.

The Annals of Thoracic Surgery, Vol 39, 149-154, Copyright © 1985 by The Society of Thoracic Surgeons


ARTICLES

Further cardiac transplant procedures in patients with heterotopic heart transplants

D Novitzky, DK Cooper, RP Lanza and CN Barnard

Seven patients with heterotopic heart transplants have undergone further heart transplant procedures. In 5, the first heterotopically placed donor heart was excised and replaced with the second donor heart. In 2, the first heterotopic donor heart was left in situ and the patient's own heart (then nonfunctioning) was excised and replaced by the second donor heart; thus, these patients underwent orthotopic transplantation and were left with two donor hearts. The decision to perform retransplantation in a patient undergoing irreversible acute rejection is usually straightforward, but the timing of a further transplant procedure in a patient with advanced graft arteriosclerosis may present a difficult problem. Two of the 7 patients in this series died of infectious complications within the first 3 months after retransplantation. A third patient acutely rejected the second donor heart within 5 days, but survived an additional 17 months with the support of his own cardiomyopathic heart. Four patients remain alive and well between 5 and 36 months following the second transplant and between 17 and 54 months following the first transplant procedure.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
O. Mangoush, T. Bahrami, F. De Robertis, J. Swinburn, N. Banner, M. H. Yacoub, and A. Khaghani
Regurgitation of the Native Aortic Valve Caused by Thrombus Formation After Heterotopic Heart Transplantation
Ann. Thorac. Surg., November 1, 2004; 78(5): 1821 - 1823.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. Martinelli, M. Rinaldi, C. Pederzolli, C. Goggi, N. Pederzolli, and M. Vigano'
Successful Treatment of Aortic Dissection After Heterotopic Heart Transplantation
Ann. Thorac. Surg., April 1, 1995; 59(4): 990 - 992.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1985 by The Society of Thoracic Surgeons.